CNS Healthcare

What CNS Healthcare does

CNS Healthcare, legally Clinical Neuroscience Solutions, Inc., is a privately held multi-site clinical research organization founded in 1996 and headquartered in Orlando, Florida. The company operates five dedicated multi-specialty research sites across Orlando (Downtown and SODO), Jacksonville (South and UNC), and Memphis, supported by a 26-foot mobile health and clinical research unit that extends trial access into rural and underrepresented communities. CNS Healthcare conducts Phase 1 through Phase 4 clinical trials across CNS/neuroscience, psychiatry, cardiovascular, metabolic, dermatology, vaccines, and emerging psychedelic indications for pediatric, adult, and geriatric patient populations.

The company's core technology is its proprietary SiteCentric CTMS, developed in-house since 2010, which integrates modules for patient recruiting, electronic data capture, compliance and quality assurance, business development, and electronic investigator site file management. Clinical operations are staffed by board-certified Principal Investigators across psychiatry, neurology, internal medicine, endocrinology, and family medicine, supported by nurse practitioners, clinical research coordinators, regulatory/QA specialists, and project managers. The site network reports a clean FDA audit history, formal internal SOPs, and relationships with all major Central IRBs.

The business model is professional services revenue generated by executing sponsor-funded clinical trial protocols on a site-network basis. CNS Healthcare serves as a contracted research site for pharmaceutical sponsors (Pfizer, Merck, Eli Lilly, Janssen, AstraZeneca, BMS, Biogen, Amgen, Moderna, J&J, and others) and Contract Research Organizations (Parexel, Covance, PPD, Fortrea, ICON, and others). Patient participation is provided at no cost with compensation for time and travel. The company is founder/management-owned with no disclosed external funding, private equity, or venture capital backing, and operates without subsidiaries or a parent company structure.

Name

CNS Healthcare

Legal name

Clinical Neuroscience Solutions, Inc.

Website

https://cnshealthcare.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

101–250 employees

Short description

CNS Healthcare operates five dedicated Phase 1-4 clinical research sites in Orlando, Jacksonville, and Memphis plus a mobile unit. The company conducts trials for pharmaceutical sponsors and CROs across CNS, psychiatry, cardiovascular, metabolic, dermatology, vaccine, and psychedelic indications.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Clinical trial services
• Clinical research sites
• Phase I-IV trials
• Patient recruitment services
• Drug development research

Headquarters

HQ city

Jacksonville

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Clinical Research Services: CNS Healthcare generates revenue by conducting clinical trials on behalf of pharmaceutical sponsors and CROs. Services include patient recruitment, study execution, data management, regulatory compliance, and site infrastructure. The company operates as a site network performing contract research work for drug development programs.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

CNS Healthcare conducts Phase 1-4 clinical trials on behalf of pharmaceutical sponsors, biotechs, and CROs across CNS, cardiovascular, metabolic, dermatology, and vaccine therapeutic areas. The company operates as a multi-site site network of five dedicated research clinics plus a mobile research unit, delivering patient recruitment, study execution, data management, and regulatory compliance services. Patients access trial participation at no cost, with no insurance required and compensation provided for time and travel.

Product overview

CNS Healthcare operates as a multi-site clinical research organization (CRO) conducting Phase I-IV clinical trials for pharmaceutical and biotech sponsors. The company runs five dedicated research sites in Orlando and Jacksonville, FL, and Memphis, TN, plus a mobile health unit. Their proprietary CTMS platform (sitecentric.com) supports site operations including patient recruiting, EDC, compliance/QA, and business development modules. Services include traditional site-based trials and virtual/decentralized trial capabilities. The company specializes in CNS/neuroscience, cardiovascular, metabolic, dermatological, and vaccine research across pediatric, adult, and geriatric patient populations.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services End-to-end clinical trial services for pharmaceutical sponsors, biotech companies, and CROs, including patient recruitment, study execution, data management, and regulatory compliance for Phase 1-4 trials across CNS, cardiovascular, metabolic, dermatology, and vaccine therapeutic areas in pediatric, adult, and geriatric populations.
• SiteCentric CTMS Proprietary Clinical Trial Management System (CTMS) built by CNS Healthcare for clinical research sites, featuring modules for CTMS, eISF, Compliance & Quality Assurance, Business Development, and Patient Recruiting. Designed as a site-facing platform to integrate site operations, electronic data capture, and protocol compliance.
• Mobile Health & Clinical Research Unit 26-foot mobile research unit equipped with two private state-of-the-art mobile exam rooms, CLIA-waived lab capabilities, full private bathroom with sink, exam room table, draw chair, temperature monitoring, and refrigeration. Travels to rural and underrepresented communities to deliver health screenings and mobile clinical trial services, extending trial access to diverse patient populations.

Quantifiable outcome

• 106+ drugs approved by FDA and brought to market through CNS Healthcare clinical trials
• +3 more outcomes

Named customers13 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

20 partnerships are on record, tiered core.

• PfizercoreStrategic or Co-development PartnerPharmaceutical partner for clinical trials. CNS Healthcare has conducted trials contributing to drugs brought to market through their research partnership.
• MerckcoreStrategic or Co-development PartnerPharmaceutical partner for clinical trials. One of the major pharma companies CNS Healthcare has partnered with to conduct clinical research.
• Eli LillycoreStrategic or Co-development PartnerPharmaceutical partner for clinical trials contributing to CNS and other therapeutic area drug development.
• JanssencoreStrategic or Co-development PartnerPharmaceutical partner including involvement in Janssen COVID-19 Vaccine trials. CNS Healthcare has conducted numerous trials for Janssen.
• AstraZenecacoreStrategic or Co-development PartnerPharmaceutical partner for clinical trials across multiple therapeutic areas.
• Bristol Myers SquibbcoreStrategic or Co-development PartnerPharmaceutical partner for clinical trials contributing to drug development programs.
• BiogencoreStrategic or Co-development PartnerBiotechnology partner for clinical trials including neurological disorders research.
• AmgencoreStrategic or Co-development PartnerPharmaceutical partner for clinical trials across therapeutic areas.
• GlaxoSmithKlinecoreStrategic or Co-development PartnerPharmaceutical partner for clinical trials.
• NovartiscoreStrategic or Co-development PartnerPharmaceutical partner for clinical trials.
• RochecoreStrategic or Co-development PartnerPharmaceutical partner for clinical trials.
• ParexelcoreChannel Partner/ Reseller/ DistributorCRO partner for contract clinical research services.
• CovancecoreChannel Partner/ Reseller/ DistributorCRO partner for contract clinical research services.
• PRA Health SciencescoreChannel Partner/ Reseller/ DistributorCRO partner for contract clinical research services.
• PPDcoreChannel Partner/ Reseller/ DistributorCRO partner for contract clinical research services.
• Fortrea CROcoreChannel Partner/ Reseller/ DistributorCRO partner for contract clinical research services.
• ICONcoreChannel Partner/ Reseller/ DistributorCRO partner for contract clinical research services.
• INC ResearchcoreChannel Partner/ Reseller/ DistributorCRO partner for contract clinical research services.
• ModernacoreStrategic or Co-development PartnerBiotechnology partner involved in COVID-19 vaccine research.
• Johnson & JohnsoncoreStrategic or Co-development PartnerPharmaceutical partner for clinical trials.

Scale indicators8 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Velocity Clinical Research: Multi-site clinical research site network with comparable Phase 1-4 trial execution capabilities and similar sponsor-facing value proposition. Operates a larger footprint than CNS, making it a directly comparable site-network peer.
• Hassman Research Institute (HRI): Specialized CNS-focused clinical research site with deep psychiatry and neurology trial experience. Highly comparable in therapeutic focus and sponsor profile, though smaller in site count.
• Atlanta Center for Medical Research: Multi-specialty clinical research site with strong CNS and internal medicine capabilities. Comparable business model of operating dedicated research sites for pharmaceutical sponsors.
• Meridien Research: Multi-site clinical research organization operating across the Southeast US with comparable multi-specialty trial focus. Direct competitor for similar sponsor and patient populations in the Florida region.
• Woodland Research Center: Multi-specialty clinical research site with similar therapeutic breadth and sponsor services. Comparable in size, therapeutic focus, and Phase 1-4 capabilities to CNS Healthcare.
• JBR Clinical Research: Multi-specialty clinical research site with comparable Phase 2-4 capabilities across CNS, metabolic, and general medicine indications. Direct peer in size and sponsor profile.

Broad incumbents

• Medpace: Mid-to-large CRO with strong site management operations and CNS/neurology franchise. A broader incumbent that competes with CNS for sponsor clinical trial execution, but operates a global, full-service CRO model.
• ICON plc: Global CRO and site services provider that partners with pharmaceutical sponsors on CNS and other therapeutic trials. Functions as a broader incumbent in the same end market.
• Syneos Health: Large CRO and clinical site network with established CNS/neuroscience franchise. Competes for the same sponsor relationships and trial awards as CNS Healthcare, but at greater scale.

Regional players

• Florida Clinical Research Center: Florida-based clinical research site network operating in the same geography as CNS Healthcare. Comparable in site-network model but regionally focused, creating direct competition for Florida-based patient recruitment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/cnshealthcare
• YouTubeyoutube.com/c/cnshealthcare
• Facebookfacebook.com/cnshealthcare
• LinkedInlinkedin.com/company/cns-healthcare
• Instagraminstagram.com/cnshealthcare/?hl=en

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CNS Healthcare